Glibornuride: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
| UNII = VP83E7434R | | UNII = VP83E7434R | ||
| verifiedrevid = 444003955 | | verifiedrevid = 444003955 | ||
|ImageFile= | |ImageFile=Glibornuride03.png | ||
|ImageSize=200px | |ImageSize=200px | ||
Line 36: | Line 36: | ||
}} | }} | ||
}} | }} | ||
==Overview== | |||
'''Glibornuride''' ([[International Nonproprietary Name|INN]]) is an [[anti-diabetic drug]] from the group of [[sulfonylurea]]s.<ref>{{cite journal |author=Haupt E, Köberich W, Beyer J, Schöffling K |title=Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects |journal=Diabetologia |volume=7 |issue=6 |pages=449–54 |date=December 1971 |pmid=5004178 |doi=10.1007/bf01212061}}</ref> | '''Glibornuride''' ([[International Nonproprietary Name|INN]]) is an [[anti-diabetic drug]] from the group of [[sulfonylurea]]s.<ref>{{cite journal |author=Haupt E, Köberich W, Beyer J, Schöffling K |title=Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects |journal=Diabetologia |volume=7 |issue=6 |pages=449–54 |date=December 1971 |pmid=5004178 |doi=10.1007/bf01212061}}</ref> | ||
Revision as of 20:57, 6 April 2015
Template:Chembox E number
Names | |
---|---|
IUPAC name
1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
| |
Identifiers | |
3D model (JSmol)
|
|
DrugBank | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
| |
Properties | |
C18H26N2O4S | |
Molar mass | 366.48 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
Overview
Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]
References
- ↑ Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.
Categories:
- Pages with script errors
- CS1 maint: Multiple names: authors list
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without EBI source
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed DrugBank identifier
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Alcohols
- Drug
- Sulfonylureas